期刊文献+

利妥昔单抗治疗难治性Waldenstrom巨球蛋白血症1例并文献复习

下载PDF
导出
出处 《临床荟萃》 CAS 北大核心 2008年第2期138-139,共2页 Clinical Focus
  • 相关文献

参考文献6

  • 1Treon SP, Agus DB, Link B, et al. CD20-directed antibody- mediated immunotherapy induces responses and facilitates hematologic recovery in patients with Waldenstrom's macroglobulinemia[J]. J Immunother,2001,24(3) : 272-279.
  • 2Weber DM, Dimopoulos MA, Delasalle K, et al. 2- Chlorodeoxyadenosine (2-CdA) alone or in combination for previously untreated Waldenstrom's maeroglobulinemia [J]. Semin Oneol,2003,30(2):243-247.
  • 3Treon SP, Hunter Z, Barnagan AR. CHOP plus rituximab therapy in Waldenstrom' s macroglobulinemia [J]. Clin Lymphoma, 2005,5(4) :273-277.
  • 4Dimopoulos MA, Alexanian R, Gika D, et al. Treatment of Waldenstrom's macroglobulinemia with rituximab: prognostic factors for response and progression [J]. Leuk Lymphoma, 2004,45(10) :2057-2061.
  • 5Ghobrial IM, Fonseca R, Greipp PR, et al. Initial immunoglobulin M' flare' after rituximab therapy in patients diagnosed with Waldenstrom macroglobulinemia: an Eastern Cooperative Oncology Group Study[J]. Cancer, 2004,101 (11) : 2593-2598.
  • 6Owen RG, Hillmen P, Rawstron AC. CD52 expression Waldenstrom's rnacroglobulinemia..implications for alemtuzuma therapy and response assessment[J]. Clin Lymphoma, 2005,5 (4) :278-281.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部